(Q34013416)

30 July 2017

title

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands (English)

1 reference

30 July 2017

0 references

1 reference

1

Jeroen P Jansen

1 reference

30 July 2017

Amy K O'Sullivan

2

1 reference

30 July 2017

Elly Lugtenburg

3

1 reference

30 July 2017

Lambert F R Span

4

1 reference

30 July 2017

Jeroen J W M Janssen

5

1 reference

30 July 2017

Wiro B Stam

6

1 reference

30 July 2017

publication date

10 April 2010

1 reference

30 July 2017

1 reference

30 July 2017

volume

89

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

919-926

1 reference

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Posaconazole: a broad-spectrum triazole antifungal

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Changing patterns and trends in systemic fungal infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Sickle cell anaemia: epidemiology and cost of illness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Uncommon opportunistic fungi: new nosocomial threats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Fungal infections: a growing threat

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Criteria for determining a basic health services package. Recent developments in The Netherlands.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908442

Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

29 October 2018

1 reference

12 December 2020

[The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation]

1 reference

12 December 2020

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

12 December 2020

1 reference

12 December 2020

Prophylaxis and aspergillosis--has the principle been proven?

1 reference

12 December 2020

10.1007/S00277-010-0939-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference